Procedure Codes in MS-DRG 838 - CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
The Medicare Severity Diagnosis-Related Group or MS-DRG is a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). This is the group for Procedure Codes in MS-DRG 838 - CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH Complication Comorbidity OR HIGH DOSE CHEMOTHERAPY AGENT diseases in version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.
| MS-DRG | MS-DRG Title | MCD | Relative Weight | Geometric LOS | Arithmetic LOS |
|---|---|---|---|---|---|
| 838 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT | 17 | 1.9524 Relative Weight The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization. |
2.00 Geometric Length of Stay The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average. |
5.10 Arithmetic Length of Stay The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission. |